Search Results 31-40 of 16382 for immunothérapie effets secondaires

  1. Durvalumab (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine is also used alone to treat limited-stage small cell lung cancer (LS-SCLC) that cannot be removed by surgery in patients who have received other ...

  2. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, ...

  3. Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma - Mayo Clinic

    Giving immunotherapy before surgery may be more effective at controlling disease in patients with sarcomatoid mesothelioma than giving immunotherapy alone.

  4. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

    The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which ...

  5. A Study to Evaluate Immunotherapy and Ovarian Function Among Pre-menopausal Melanoma Survivors - Mayo Clinic

    About this study. The purposes of this study are to analyze the ovarian function of female premenopausal melanoma survivors who have undergone immunotherapy ...

  6. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

    The main purpose of this study is to compare the effectiveness of bempegaldesleukin plus nivolumab versus nivolumab in patients with completely resected Stage ...

  7. Cancer treatment - Mayo Clinic

    Cancer treatments, including surgery, radiation, chemotherapy, targeted therapy and immunotherapy, are often combined to cure or control various cancers.

  8. Evaluation of Outcomes in Metastatic Gastric and Esophageal Carcinoma in Relation to Immunotherapy - Mayo Clinic

    Evaluation of Outcomes in Metastatic Gastric and Esophageal Carcinoma in Relation to Immunotherapy · Overview · Participation eligibility · Participating Mayo ...

  9. Docetaxel (intravenous route) - Mayo Clinic

    Docetaxel injection is used to treat advanced or metastatic (cancer that has spread) breast cancer in patients who have previously received other cancer ...

  10. A Study to Evaluate Immunotherapy for Non-Small Cell Lung Cancer - Mayo Clinic

    About this study. The primary objectives of this study are to evaluate safety/tolerability and immunogenicity of IMU-201 as monotherapy and in combination ...